HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a multicenter, randomized, controlled, open-label study evaluating efficacy and safety of perioperative FLOT chemotherapy plus intraoperative HIPEC versus FLOT chemotherapy alone in patients with resectable localized and locally advanced diffuse and mixed type adenocarcinoma of the stomach and Type II/III GEJ.
Epistemonikos ID: 6f799fba605dcbb1b5af9e1c0dbbb921845979b6
First added on: May 07, 2024